Collegium Pharmaceutical Inc (COLL)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $786.83M
Last updated: Nov 17, 2026 at 4:10 PM ET
Collegium Pharmaceutical Inc (COLL) Stock Chart
Collegium Pharmaceutical (COLL) has a latest price of $25.55 on Nov 17, 2026, 49.7% below its 52-week high of $50.79. Its price fell 44.4% over the past 12 months. The month-end price rose 59.0% over the 10 years through Oct 2026, a compound annual rate of 4.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $46.68 in Nov 2025 and its lowest $8.22 in May 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart COLL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for COLL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 11.1%, and over 6 months it fell 24.0%. The month-end price rose 9.4% over the 3 years through Oct 2026, a compound annual rate of 3.0%.
| Period | Change |
|---|---|
| 1 month | +11.0% |
| 3 months | -11.1% |
| 6 months | -24.0% |
| 12 months | -44.4% |
| 12 months, with dividends | -44.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +9.4% | +3.0% |
| 5 years | +21.2% | +3.9% |
| 10 years | +59.0% | +4.7% |
Price by Year
Its best calendar year was 2025, when the price rose 61.6%, and its weakest was 2018, when it fell 7.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $23.80 | -48.6% |
| 2025 | $46.30 | +61.6% |
| 2024 | $28.65 | -6.9% |
| 2023 | $30.78 | +32.7% |
| 2022 | $23.20 | +24.2% |
| 2021 | $18.68 | -6.7% |
| 2020 | $20.03 | -2.7% |
| 2019 | $20.58 | +19.9% |
| 2018 | $17.17 | -7.0% |
| 2017 | $18.46 | +18.6% |
Trading Range
The price is 10.5% above its 50-day average of $23.12 and 20.0% below its 200-day average of $31.95.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $25.55 | |
| 52-week high | $50.79 | -49.7% |
| 52-week low | $21.43 | +19.2% |
| 50-day average | $23.12 | +10.5% |
| 200-day average | $31.95 | -20.0% |
Price Risk
Over 3 years, its largest fall from a peak was 56.8%.
| Measure | Value |
|---|---|
| 1-year beta | 0.15 |
| Largest fall, 1 year | -56.8% |
| Largest fall, 3 years | -56.8% |
Valuation
Collegium Pharmaceutical traded at 6.6x earnings at the end of 2025, against a 5-year median of 6.2x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About COLL
What is COLL's 1-year price change?
Collegium Pharmaceutical's price fell 44.4% over the past 12 months. With dividends included, the 12-month total return was -44.4%.
What is COLL's 5-year price change?
Collegium Pharmaceutical's month-end price rose 21.2% over the 5 years through Oct 2026, a compound annual rate of 3.9%. These figures leave out dividends.
What is COLL's 52-week high and low?
Collegium Pharmaceutical's 52-week high is $50.79 and its 52-week low is $21.43. Its latest price of $25.55 on Nov 17, 2026 is 49.7% below the high.
What is COLL's beta?
Collegium Pharmaceutical's 1-year beta against the S&P 500 is 0.15, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 56.8%.
Is the COLL chart free?
Yes. Advanced Charting for COLL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
COLL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors